Curnutte John T 4
4 · PLIANT THERAPEUTICS, INC. · Filed Jun 9, 2025
Insider Transaction Report
Form 4
Curnutte John T
Director
Transactions
- Award
Common Stock (Right to Buy)
2025-06-05+30,000→ 30,000 totalExercise: $1.61Exp: 2035-06-05→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to such option vest and become exercisable on October 1, 2025, January 1, 2026, and April 1, 2026, respectively, and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 5, 2025 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting.